Clinical Trials Directory

Trials / Completed

CompletedNCT06221644

Synapse Alterations in MSA Patients

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Xiangya Hospital of Central South University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Synaptic loss has been implicated in various neurodegenerative conditions, yet its understanding in multiple system atrophy (MSA) remains limited. The aim of this study was to examine spatial synaptic density alterations in MSA patients and evaluate the potential of \[18F\]SynVesT-1 PET as an imaging biomarker for MSA in both diagnosis and monitoring disease severity.

Detailed description

60 MSA patients (30 MSA-P subtype and 30 MSA-C subtype) and 30 age-matched healthy controls (HCs) underwent \[18F\]SynVesT-1 PET/CT for synaptic density assessment. Visual, voxel, and volumetric region-of-interest (VOI) analyses were employed to elucidate synaptic density patterns in the MSA brain and establish visual diagnostic criteria. VOI-based computer-assisted analyses were utilized to develop diagnostic models for MSA.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TEST[18F]SynVesT-1 PET/CT60 MSA patients (30 MSA-P subtype and 30 MSA-C subtype) and 30 age-matched healthy controls (HCs) underwent \[18F\]SynVesT-1 PET/CT for synaptic density assessment

Timeline

Start date
2022-04-01
Primary completion
2022-10-30
Completion
2022-11-25
First posted
2024-01-24
Last updated
2024-01-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06221644. Inclusion in this directory is not an endorsement.